Superior Biologics: Funding, Investors & Team (Oct 2026)
Superior Biologics is a leading provider of intravenous and injectable medications for patients with chronic disorders. Our mission is to provide cost effective, patient specific services, which offer patients the freedom to lead normal lives and have optimal therapeutic outcomes. We are dedicated to understanding the changing demands of caring for patients with chronic disorders. We respond to the individual needs of patients and their families by providing personal service backed by highly qualified professionals. Superior Biologics is based in Hawthorne, New York (Westchester County), and primarily services the tri-state area of New York, New Jersey and Connecticut. Based on our pharmacy licensure, we are also able to service patients in various other states in addition to this immediate geographic area. Please contact us to find out if we are able to service your area.
Superior Biologics has raised $136M across 1 funding round on record, the most recent an undisclosed round of $136M announced in Dec 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Superior Biologics Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Superior Biologics Funding Rounds
Superior Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Superior Biologics Funding Compared to Other Biotechnology Startups
Superior Biologics' latest round of $136M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Superior Biologics in Biotechnology and Hawthorne
Companies Similar to Superior Biologics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Superior Biologics Funding FAQs
What does Superior Biologics do?
Superior Biologics is a leading provider of intravenous and injectable medications for patients with chronic disorders. Our mission is to provide cost effective, patient specific services, which offer patients the freedom to lead normal lives and have optimal therapeutic outcomes. We are dedicated to understanding the changing demands of caring for patients with chronic disorders. We respond to the individual needs of patients and their families by providing personal service backed by highly qualified professionals. Superior Biologics is based in Hawthorne, New York (Westchester County), and primarily services the tri-state area of New York, New Jersey and Connecticut. Based on our pharmacy licensure, we are also able to service patients in various other states in addition to this immediate geographic area. Please contact us to find out if we are able to service your area.
How much funding has Superior Biologics raised?
Superior Biologics has raised $136M across 1 round on record. The most recent is an undisclosed round of $136M announced in Dec 2022.
When did Superior Biologics last raise funding?
Superior Biologics' most recent funding round on record is an undisclosed round of $136M, announced in Dec 2022.
Who is the CEO of Superior Biologics?
Mark Kovinsky is listed as CEO at Superior Biologics.
Where is Superior Biologics headquartered?
Superior Biologics is based in Hawthorne, New York, United States.
How many employees does Superior Biologics have?
Superior Biologics is in the 51-100 employee band.
How does Superior Biologics' funding compare to other Biotechnology startups?
Superior Biologics' latest round of $136M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Superior Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Superior Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.